Randomized Phase II Trial of Parsatuzumab (Anti‐EGFL7) or...

The Oncologist 2017 / 10 Vol. 22; Iss. 10

Randomized Phase II Trial of Parsatuzumab (Anti‐EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First‐Line Metastatic Colorectal Cancer

García‐Carbonero, Rocío, van Cutsem, Eric, Rivera, Fernando, Jassem, Jacek, Gore, Ira, Tebbutt, Niall, Braiteh, Fadi, Argiles, Guillem, Wainberg, Zev A., Funke, Roel, Anderson, Maria, McCall, Bruce, S
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Language:
english
Journal:
The Oncologist
DOI:
10.1634/theoncologist.2016-0133erratum
Date:
October, 2017
File:
PDF, 29 KB
english, 2017
Conversion to is in progress
Conversion to is failed